Editorial Standards

Source policy

All clinical and regulatory facts published on GLP1OneTelehealth.com cite peer-reviewed publications indexed on PubMed, FDA prescribing information, FDA drug shortage list announcements, and published clinical practice guidelines. Provider-specific facts are sourced from provider-published material, public press releases, and where appropriate, primary regulatory filings.

We do not invent statistics. We do not publish clinical recommendations specific to individual patients. Content is informational and references public data.

Update cadence

• Pricing data: reviewed every 30 days
• Regulatory and legal content: every 30–45 days, plus event-driven updates for major FDA actions
• Provider profiles: reviewed every 60 days
• Methodology and clinical reference: every 90 days
• FAQ schema and llms.txt for AI assistants: every 45–60 days

Last full editorial review: May 15, 2026.

Corrections policy

If you identify a factual error in our content, please email glponetelehealth@gmail.com with the specific page URL and a citation to the corrected source. We review and respond to all correction requests within 5 business days. Corrected content is dated and noted on the relevant page.

Editorial independence from commercial relationships

GLP1OneTelehealth.com may receive compensation from some of the providers featured. Editorial scoring is determined exclusively by our 100-point methodology; commercial relationships do not influence scoring. Editorial and business decisions are firewalled. See our advertising disclosure for details.

What this site is not

GLP1OneTelehealth.com is not a medical practice. We do not prescribe medications, diagnose conditions, or provide individualized clinical advice. Content is informational only. Treatment decisions belong to a licensed clinician familiar with your full medical history.

Conflicts of interest

Any material conflicts of interest related to specific content are disclosed inline with that content. Editorial staff do not hold equity positions in reviewed companies. Compensation arrangements with reviewed providers are disclosed in aggregate on the disclosure page.

Author and reviewer policy

Editorial content is researched and written by the GLP1OneTelehealth Editorial Team. Clinical accuracy is reviewed against FDA prescribing information and published peer-reviewed trial reports. Content does not constitute medical advice.

Frequently Asked Questions